WHO Finalizing Guidance For Launch Of Biosimilar Prequalification Pilot
Executive Summary
The WHO’s prequalification pilot for biosimilars is to start next month in an effort to make some of the most expensive cancer drugs more widely available to patients in low- and middle-income countries.
You may also be interested in...
WHO Kick-Starts Pilot For Prequalification Of Biologics/Biosimilars
Manufacturers are being invited to submit expressions of interest in relation to two anticancer monoclonal antibodies on the WHO's essential list of medicines.
WHO Kick-Starts Pilot For Prequalification Of Biologics/Biosimilars
Manufacturers are being invited to submit expressions of interest in relation to two anticancer monoclonal antibodies on the WHO's essential list of medicines.
Advanced Therapy Developers Urged To Monitor Major EU Proposal On Using Blood, Tissues & Cells
Companies have the opportunity to tell the European Commission what they think about its proposed regulation that would overhaul the rules governing the use of substances of human origin.